During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.35 million, with the beta value of the company hitting -0.56. At the end of the trading day, the stock’s price was $2.17, reflecting an intraday loss of -1.36% or -$0.03. The 52-week high for the LYEL share is $3.97, that puts it down -82.95 from that peak though still a striking 39.17% gain since the share price plummeted to a 52-week low of $1.32. The company’s market capitalization is $553.22M, and the average trade volume was 916.21K shares over the past three months.
Lyell Immunopharma Inc (NASDAQ:LYEL) trade information
Lyell Immunopharma Inc (LYEL) registered a -1.36% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.36% in intraday trading to $2.17, hitting a weekly high. The stock’s 5-day price performance is -2.69%, and it has moved by 6.37% in 30 days. Based on these gigs, the overall price performance for the year is 14.81%.
Lyell Immunopharma Inc (LYEL) estimates and forecasts
Statistics show that Lyell Immunopharma Inc has underperformed its competitors in share price, compared to the industry in which it operates. Lyell Immunopharma Inc (LYEL) shares have gone up 39.10% during the last six months, with a year-to-date growth rate less than the industry average at 9.68% against 10.40.
As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 65k and 27k respectively.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -15.28%. While earnings are projected to return 6.33% in 2024, the next five years will return -7.90% per annum.
LYEL Dividends
Lyell Immunopharma Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
